Disease Burden in PSAC
Cross-source consensus on Disease Burden in PSAC from 1 sources and 3 claims.
1 sources · 3 claims
Risks & contraindications
Evidence quality
Highlighted claims
- PSAC face a dual disease burden comprising high-prevalence infectious diseases and rising non-communicable diseases. — Three decades of clinical trials in Portuguese-speaking Africa: a comprehensive scoping review protocol
- NCDs collectively account for 32%–70% of deaths across PSAC countries. — Three decades of clinical trials in Portuguese-speaking Africa: a comprehensive scoping review protocol
- Shared disease challenges across PSAC create opportunities for collaborative regional research that currently remains sparse and fragmented. — Three decades of clinical trials in Portuguese-speaking Africa: a comprehensive scoping review protocol